LBO — FREMONT HEALTH
IRR: 19.4% | MOIC: 2.43x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
19.4%
IRR
2.43x
MOIC
$94.4M
Entry EV
$158.6M
Exit EV
$48.6M
Equity Invested
Sources & Uses
S&UTotal · $94.4M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $36.7M | 38.8% | |
| Sub Debt | $9.2M | 9.7% | |
| Equity | $48.6M | 51.5% | |
| Enterprise Value | $91.6M | 97.1% | |
| Transaction Fees | $2.7M | 2.9% | |
| Total Uses | $94.4M | 100.0% |
Interpretation
INTAt 2.43x MOIC and 19.4% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $15.1M |
| Exit Ev | $158.6M |
| Net Debt At Exit | $40.6M |
| Equity At Exit | $118.0M |
| Equity Invested | $48.6M |
| Total Value Created | $69.4M |
| Value From Growth | $62.4M |
| Value From Multiple | $4.6M |
| Value From Deleveraging | $5.2M |